GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **576 - 600** of **4050** in total

« First

‹ Prev

…

20

21

22

23

24

25

26

27

28

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgG	Patient 2	24	mild	G61751GZ	40
IgG	Patient 2	24	mild	G78074HX	40
IgM	Patient 2	24	mild	G00051MO	40
IgG	Patient 2	3	mild	G96865DJ	40
IgM	Patient 2	3	mild	G00053MO	40
IgM	Patient 2	3	mild	G24432YB	40
IgM	Patient 2	3	mild	G76615YG	40
IgG	Patient 3	-180	mild	G00048MO	40
IgG	Patient 3	-180	mild	G27689OB	40
IgG	Patient 3	-180	mild	G31265MS	40
IgG	Patient 3	-180	mild	G53168IY	40
IgG	Patient 3	4	mild	G61751GZ	40
IgG	Patient 3	4	mild	G89993FE	40
IgM	Patient 1	10	moderate	G00065MO	41
IgM	Patient 1	10	moderate	G42346AP	41
IgM	Patient 1	10	moderate	G78255UI	41
IgM	Patient 1	22	moderate	G11460AB	41
IgM	Patient 1	22	moderate	G12200GB	41
IgM	Patient 1	22	moderate	G86566MF	41
IgM	Patient 1	22	moderate	G99603GB	41
IgG	Patient 1	6	moderate	G68461PT	41
IgM	Patient 1	6	moderate	G18057VI	41
IgM	Patient 1	6	moderate	G21460SG	41
IgM	Patient 1	6	moderate	G63074CQ	41
IgM	Patient 1	6	moderate	G78074HX	41